Osaic Holdings’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,223
Closed -$3.49M 7647
2022
Q3
$3.49M Sell
14,223
-168
-1% -$45.4K 0.01% 1243
2022
Q2
$3.56M Sell
14,391
-245
-2% -$66.1K 0.01% 1264
2022
Q1
$5.19M Buy
14,636
+9,371
+178% +$2.88M 0.01% 1186
2021
Q4
$1.89M Buy
5,265
+831
+19% +$281K ﹤0.01% 1830
2021
Q3
$1.44M Buy
4,434
+48
+1% +$16.3K ﹤0.01% 2014
2021
Q2
$1.37M Sell
4,386
-126
-3% -$38.7K ﹤0.01% 2058
2021
Q1
$1.44M Sell
4,512
-3
-0.1% -$960 ﹤0.01% 1914
2020
Q4
$1.46M Sell
4,515
-15,171
-77% -$4.2M ﹤0.01% 1705
2020
Q3
$5.45M Buy
19,686
+12,269
+165% +$3.53M 0.02% 725
2020
Q2
$1.79M Sell
7,417
-3,684
-33% -$740K 0.01% 1316
2020
Q1
$432K Buy
+11,101
New +$1.84M ﹤0.01% 2227

Other funds holding ABMD

Osaic Holdings's ABMD Position: Q4 2022 in Review

Osaic Holdings sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 14,223 shares — an estimated $3.49M sold.

Osaic Holdings first reported a position in ABMD in Q1 2020 and held it in 11 quarters. The position peaked at $5.45M in Q3 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Osaic Holdings reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Osaic Holdings sold 14,223 Abiomed Inc shares in Q4 2022, an estimated $3.49M.
  • Osaic Holdings first reported a position in Abiomed Inc in Q1 2020 and held it in 11 quarters.
  • Osaic Holdings's Abiomed Inc position peaked at $5.45M in Q3 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Osaic Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.